DK0975360T3 - Bovint respiratorisk og enterisk coronavirus som vaccine - Google Patents

Bovint respiratorisk og enterisk coronavirus som vaccine

Info

Publication number
DK0975360T3
DK0975360T3 DK98907727T DK98907727T DK0975360T3 DK 0975360 T3 DK0975360 T3 DK 0975360T3 DK 98907727 T DK98907727 T DK 98907727T DK 98907727 T DK98907727 T DK 98907727T DK 0975360 T3 DK0975360 T3 DK 0975360T3
Authority
DK
Denmark
Prior art keywords
vaccine
bovine respiratory
bovine
coronavirus
enteric coronavirus
Prior art date
Application number
DK98907727T
Other languages
Danish (da)
English (en)
Inventor
Lisa C Stine
Michael J Mcginley
Gary A Anderson
Douglas L Stine
Karen K Brown
Andre D Dory
Adrian Liem
Original Assignee
Bayer Corp
Immtech Biolog Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp, Immtech Biolog Llc filed Critical Bayer Corp
Application granted granted Critical
Publication of DK0975360T3 publication Critical patent/DK0975360T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98907727T 1997-03-10 1998-03-04 Bovint respiratorisk og enterisk coronavirus som vaccine DK0975360T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81431197A 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
DK0975360T3 true DK0975360T3 (da) 2006-11-27

Family

ID=25214684

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98907727T DK0975360T3 (da) 1997-03-10 1998-03-04 Bovint respiratorisk og enterisk coronavirus som vaccine

Country Status (13)

Country Link
EP (1) EP0975360B1 (de)
JP (1) JP2001519781A (de)
KR (1) KR100531491B1 (de)
CN (1) CN1283315C (de)
AT (1) ATE334697T1 (de)
AU (1) AU725439B2 (de)
BR (1) BR9808226A (de)
CA (1) CA2231591A1 (de)
DE (1) DE69835424T2 (de)
DK (1) DK0975360T3 (de)
ES (1) ES2270508T3 (de)
NZ (1) NZ337702A (de)
WO (1) WO1998040097A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
JP2005508945A (ja) * 2001-10-06 2005-04-07 メリアル リミテッド Ｃｐｇ配合物及び関連方法
CN102021147B (zh) * 2003-03-24 2016-08-03 港大科桥有限公司 引起严重急性呼吸道综合征(sars)的新型人病毒及其应用
EP1649053A4 (de) * 2003-06-18 2006-10-18 Chinese Nat Human Genome Ct Sh Charakterisierung der frühesten stufen des virus des schweren akuten respiratorischen syndroms (sars) und verwendungen davon
CN1318580C (zh) * 2003-07-10 2007-05-30 北京科兴生物制品有限公司 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法
WO2011056175A1 (en) 2009-11-06 2011-05-12 Intervet International B.V. Methods of immunizing pregnant heifers at three months of gestation
MX2017002803A (es) 2014-09-03 2017-06-09 Intervet Int Bv Coronavirus bovino atenuado y vacunas relacionadas.
CN111117975A (zh) * 2020-01-03 2020-05-08 西南民族大学 牛冠状病毒he基因重组株及其制备的灭活疫苗和应用
CN113322241B (zh) * 2021-05-14 2023-06-13 金宇保灵生物药品有限公司 一种牛副流感病毒3型病毒株bpiv3-nm及其应用
CN117286111B (zh) * 2023-03-13 2024-06-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 牛冠状病毒分离株、稳定表达牛冠状病毒n蛋白细胞系及在构建反向遗传操作系统中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580778A (en) * 1994-06-15 1996-12-03 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
PT833903E (pt) * 1995-06-12 2004-11-30 Univ Kansas State Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino

Also Published As

Publication number Publication date
BR9808226A (pt) 2000-05-16
CA2231591A1 (en) 1998-09-10
ATE334697T1 (de) 2006-08-15
CN1250380A (zh) 2000-04-12
AU6346598A (en) 1998-09-29
DE69835424D1 (de) 2006-09-14
KR100531491B1 (ko) 2005-11-28
DE69835424T2 (de) 2007-02-08
ES2270508T3 (es) 2007-04-01
AU725439B2 (en) 2000-10-12
WO1998040097A2 (en) 1998-09-17
EP0975360A2 (de) 2000-02-02
KR20000075775A (ko) 2000-12-26
NZ337702A (en) 2001-05-25
CN1283315C (zh) 2006-11-08
EP0975360B1 (de) 2006-08-02
JP2001519781A (ja) 2001-10-23
WO1998040097A3 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
NO991524L (no) Vaksiner
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
ATE264691T1 (de) Newcastle-krankheitsvirus-kombinationsimpfstoff
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
DZ2462A1 (fr) Vaccin antigrippal.
NO20041917L (no) Spesifikke midler som binder humant angiopoietin-2
DE60125797D1 (de) Impfstoffzusammesetzung
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
AU2001258373A1 (en) Method for identifying helicobacter antigens
ZA200000370B (en) Novel antigenic class of avian reoviruses.
BR0002826A (pt) Desfolhadeira mecânica
ATE372129T1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
DK1141305T3 (da) Kimært gen som koder for de antigene determinanter af fire proteiner af L. infantum
ES2184987T3 (es) Formas de administracion solidas de liberacion instantanea y procedimiento para su preparacion.
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
FI972389A0 (fi) Uusi menetelmä ranitidiinin valmistamiseksi